Insights
Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars
The industry report you’ve been waiting for. Today biosimilars seem to be the topic of conversation everywhere. Why? Humira. The launch of Humira biosimilars will be
AlignRx Highlighted on Self-Funded with Spencer Podcast
Brian Shonat, Goodroot’s area vice president of business development, recently joined Spencer Smith on the Self-Funded with Spencer podcast to talk AlignRx, PBM contracts, specialty
Webinar on Demand: Meeting the Mandate—The TPA Path to RxDC Success
The RxDC Reporting Deadline is Approaching—Are you Prepared? At AlignRx, we provide our valued TPA partners and their employer groups with year-round pharmacy consulting and
RxDC TPA Guide – What TPAs Need to Know
The RxDC Reporting Deadline Is Approaching—Are You Prepared? The Consolidated Appropriations Act has a new Rx mandate for your employer groups and the deadline is
5 Must-ask Questions Before the PBM RFP Process
Read the full article by AlignRx COO Greg Sanderson on Employee Benefit News. While it may seem early to be thinking about 2023, summer is
How Specialty Drug ‘Solution Stacking’ Can Rein in Pharmacy Benefit Costs
Brokers and employer groups alike know that 5% to 10% percent of insured workers and their dependents drive 50% to 60% of the cost of
Prediabetes and Type 2 Diabetes Screening
What is happening: In August 2021 the United States Preventive Services Task Force (USPSTF) recommended that adults, aged 35 to 70 years who are overweight
What Employers, TPAs and Brokers Need to Know About COVID 10 Home Testing
January 10, 2022, the U.S. Department of Labor (DOL) issued guidance related to insurance coverage for COVID OTC testing, provided at no cost to covered
How Digital Therapeutics Are Paid For Has Huge Implications
Digital Therapeutics (DTx) have been increasingly popular since smartphones and wearable tech have become ubiquitous. The pandemic has set them on a trajectory for massive
Stay Connected
"*" indicates required fields
